These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 19368811)

  • 21. Neuroanatomical, molecular genetic, and behavioral correlates of fragile X syndrome.
    Koukoui SD; Chaudhuri A
    Brain Res Rev; 2007 Jan; 53(1):27-38. PubMed ID: 16844227
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunocytochemical and biochemical characterization of FMRP, FXR1P, and FXR2P in the mouse.
    Bakker CE; de Diego Otero Y; Bontekoe C; Raghoe P; Luteijn T; Hoogeveen AT; Oostra BA; Willemsen R
    Exp Cell Res; 2000 Jul; 258(1):162-70. PubMed ID: 10912798
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The role of the postsynaptic density in the pathology of the fragile X syndrome.
    Kindler S; Kreienkamp HJ
    Results Probl Cell Differ; 2012; 54():61-80. PubMed ID: 22009348
    [TBL] [Abstract][Full Text] [Related]  

  • 24. RNA interference: a new mechanism by which FMRP acts in the normal brain? What can Drosophila teach us?
    Siomi H; Ishizuka A; Siomi MC
    Ment Retard Dev Disabil Res Rev; 2004; 10(1):68-74. PubMed ID: 14994291
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression of fragile X mental retardation-1 gene with nuclear export signal mutation changes the expression profiling of mouse cerebella immortal neuronal cell.
    Hu L; Chen Y; Evers S; Shen Y
    Proteomics; 2005 Oct; 5(15):3979-90. PubMed ID: 16130171
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of reduced expression of fragile X mental retardation protein in neurons and increased expression in astrocytes in idiopathic and syndromic autism (duplications 15q11.2-q13).
    Wegiel J; Brown WT; La Fauci G; Adayev T; Kascsak R; Kascsak R; Flory M; Kaczmarski W; Kuchna I; Nowicki K; Martinez-Cerdeno V; Wisniewski T; Wegiel J
    Autism Res; 2018 Oct; 11(10):1316-1331. PubMed ID: 30107092
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Localization of FMRP-associated mRNA granules and requirement of microtubules for activity-dependent trafficking in hippocampal neurons.
    Antar LN; Dictenberg JB; Plociniak M; Afroz R; Bassell GJ
    Genes Brain Behav; 2005 Aug; 4(6):350-9. PubMed ID: 16098134
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The fragile X mental retardation protein interacts with a distinct mRNA nuclear export factor NXF2.
    Lai D; Sakkas D; Huang Y
    RNA; 2006 Aug; 12(8):1446-9. PubMed ID: 16790844
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Exceptional good cognitive and phenotypic profile in a male carrying a mosaic mutation in the FMR1 gene.
    Govaerts LC; Smit AE; Saris JJ; VanderWerf F; Willemsen R; Bakker CE; De Zeeuw CI; Oostra BA
    Clin Genet; 2007 Aug; 72(2):138-44. PubMed ID: 17661818
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neuron-Specific FMRP Roles in Experience-Dependent Remodeling of Olfactory Brain Innervation during an Early-Life Critical Period.
    Golovin RM; Vest J; Broadie K
    J Neurosci; 2021 Feb; 41(6):1218-1241. PubMed ID: 33402421
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fragile X mental retardation protein is required for chemically-induced long-term potentiation of the hippocampus in adult mice.
    Shang Y; Wang H; Mercaldo V; Li X; Chen T; Zhuo M
    J Neurochem; 2009 Nov; 111(3):635-46. PubMed ID: 19659572
    [TBL] [Abstract][Full Text] [Related]  

  • 32. New insights into Fragile X syndrome. Relating genotype to phenotype at the molecular level.
    Pozdnyakova I; Regan L
    FEBS J; 2005 Feb; 272(3):872-8. PubMed ID: 15670167
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fragile X syndrome: from molecular genetics to therapy.
    D'Hulst C; Kooy RF
    J Med Genet; 2009 Sep; 46(9):577-84. PubMed ID: 19724010
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fragile X protein expression is linked to visual functions in healthy male volunteers.
    Kéri S; Benedek G
    Neuroscience; 2011 Sep; 192():345-50. PubMed ID: 21749915
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Contrast, motion, perceptual integration, and neurocognition in schizophrenia: the role of fragile-X related mechanisms.
    Kelemen O; Kovács T; Kéri S
    Prog Neuropsychopharmacol Biol Psychiatry; 2013 Oct; 46():92-7. PubMed ID: 23838275
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Abnormal neuronal morphology and neurochemistry in the auditory brainstem of Fmr1 knockout rats.
    Ruby K; Falvey K; Kulesza RJ
    Neuroscience; 2015 Sep; 303():285-98. PubMed ID: 26166728
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular diagnosis of Fragile X syndrome.
    Sofocleous C; Kolialexi A; Mavrou A
    Expert Rev Mol Diagn; 2009 Jan; 9(1):23-30. PubMed ID: 19099346
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Developmentally-programmed FMRP expression in oligodendrocytes: a potential role of FMRP in regulating translation in oligodendroglia progenitors.
    Wang H; Ku L; Osterhout DJ; Li W; Ahmadian A; Liang Z; Feng Y
    Hum Mol Genet; 2004 Jan; 13(1):79-89. PubMed ID: 14613971
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression of fragile X mental retardation protein in neurons and glia of the developing and adult mouse brain.
    Gholizadeh S; Halder SK; Hampson DR
    Brain Res; 2015 Jan; 1596():22-30. PubMed ID: 25446451
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Decreased GABA(A) receptor expression in the seizure-prone fragile X mouse.
    El Idrissi A; Ding XH; Scalia J; Trenkner E; Brown WT; Dobkin C
    Neurosci Lett; 2005 Apr; 377(3):141-6. PubMed ID: 15755515
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.